Emanuel Della-Torre

InstitutionSan Raffaele Scientific Institute
AddressMilan
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 18 Covid-19 publications, with a maximum of 3 publications in May 2020 and August 2020
    All Publications
    Bar chart showing 52 publications over 13 distinct years, with a maximum of 13 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ramirez GA, Della-Torre E, Moroni L, Yacoub MR, Dagna L. Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'. Ann Rheum Dis. 2021 Oct; 80(10):e159. PMID: 34031031.
      Citations: 5     Fields:    Translation:Humans
    2. Ramirez GA, Della-Torre E, Tresoldi M, Scarpellini P, Ciceri F, Dagna L, Yacoub MR. Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19. Clin Microbiol Infect. 2021 08; 27(8):1190-1192. PMID: 34015530.
      Citations: 1     Fields:    Translation:Humans
    3. Della-Torre E, Lanzillotta M, Campochiaro C, Cavalli G, De Luca G, Tomelleri A, Boffini N, De Lorenzo R, Ruggeri A, Rovere-Querini P, Castagna A, Landoni G, Tresoldi M, Ciceri F, Zangrillo A, Dagna L. Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation. Front Immunol. 2021; 12:675678. PMID: 33995419.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    4. Ramirez GA, Bozzolo EP, Gobbi A, Castelli E, Centurioni C, DI Meo M, Della Torre E, DI Scala F, Morgillo A, Marinosci A, Miglio M, Scarpellini P, Tassan Din C, Castiglioni B, Oltolini C, Ripa M, DI Terlizzi G, DA Prat V, Damanti S, Scotti R, DI Lucca G, Baiardo Redaelli M, Plumari VP, Moizo E, Carcó F, Silvani P, DE Cobelli F, Landoni G, Tresoldi M. Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19. Panminerva Med. 2021 Apr 16. PMID: 33860653.
      Citations: 3     Fields:    
    5. Cavalli G, Larcher A, Tomelleri A, Campochiaro C, Della-Torre E, De Luca G, Farina N, Boffini N, Ruggeri A, Poli A, Scarpellini P, Rovere-Querini P, Tresoldi M, Salonia A, Montorsi F, Landoni G, Castagna A, Ciceri F, Zangrillo A, Dagna L. Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study. Lancet Rheumatol. 2021 Apr; 3(4):e253-e261. PMID: 33655218.
      Citations: 37     
    6. Cavalli G, Farina N, Campochiaro C, De Luca G, Della-Torre E, Tomelleri A, Dagna L. Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic. Front Pharmacol. 2020; 11:598308. PMID: 33442386.
      Citations: 5     
    7. Natalello G, De Luca G, Gigante L, Campochiaro C, De Lorenzis E, Verardi L, Paglionico A, Petricca L, Martone AM, Calvisi S, Ripa M, Cavalli G, Della-Torre E, Tresoldi M, Landi F, Bosello SL, Gremese E, Dagna L. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. Microvasc Res. 2021 01; 133:104071. PMID: 32949574.
      Citations: 7     Fields:    Translation:Humans
    8. De Luca G, Cavalli G, Campochiaro C, Della-Torre E, Dagna L. Mavrilimumab for severe COVID-19 - Authors' reply. Lancet Rheumatol. 2020 Nov; 2(11):e662-e663. PMID: 33521663.
      Citations: 3     
    9. Ramirez GA, Moroni L, Della-Torre E, Gerosa M, Beretta L, Bozzolo EP, Dagna L. Systemic lupus erythematosus and COVID-19: what we know so far. Ann Rheum Dis. 2020 Aug 28. PMID: 32859611.
      Citations: 2     Fields:    
    10. Della-Torre E, Ramirez GA, Dagna L, Tresoldi M. Colchicine treatment in community healthcare setting to prevent severe COVID-19. Ann Rheum Dis. 2020 Aug 27. PMID: 32855152.
      Citations: 4     Fields:    
    11. Della-Torre E, Landoni G, Zangrillo A, Dagna L. Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al' by Cheng and Zhang. Ann Rheum Dis. 2020 Aug 19. PMID: 32816702.
      Citations: 2     Fields:    
    12. Della-Torre E, Campochiaro C, Cavalli G, De Luca G, Ciceri F, Zangrillo A, Dagna L. Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli. Ann Rheum Dis. 2020 Jul 31. PMID: 32737105.
      Citations: 5     Fields:    
    13. Della-Torre E, Campochiaro C, Cavalli G, De Luca G, Napolitano A, La Marca S, Boffini N, Da Prat V, Di Terlizzi G, Lanzillotta M, Rovere Querini P, Ruggeri A, Landoni G, Tresoldi M, Ciceri F, Zangrillo A, De Cobelli F, Dagna L. Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study. Ann Rheum Dis. 2020 10; 79(10):1277-1285. PMID: 32620597.
      Citations: 85     Fields:    Translation:HumansCellsPHPublic Health
    14. Ramirez GA, Gerosa M, Beretta L, Bellocchi C, Argolini LM, Moroni L, Della Torre E, Artusi C, Nicolosi S, Caporali R, Bozzolo EP, Dagna L. COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients. Semin Arthritis Rheum. 2020 10; 50(5):1150-1157. PMID: 32927376.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    15. De Luca G, Cavalli G, Campochiaro C, Della-Torre E, Angelillo P, Tomelleri A, Boffini N, Tentori S, Mette F, Farina N, Rovere-Querini P, Ruggeri A, D'Aliberti T, Scarpellini P, Landoni G, De Cobelli F, Paolini JF, Zangrillo A, Tresoldi M, Trapnell BC, Ciceri F, Dagna L. GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e465-e473. PMID: 32835256.
      Citations: 71     
    16. Della-Torre E, Della-Torre F, Kusanovic M, Scotti R, Ramirez GA, Dagna L, Tresoldi M. Treating COVID-19 with colchicine in community healthcare setting. Clin Immunol. 2020 08; 217:108490. PMID: 32492478.
      Citations: 34     Fields:    Translation:HumansCellsPHPublic Health
    17. Campochiaro C, Della-Torre E, Cavalli G, De Luca G, Ripa M, Boffini N, Tomelleri A, Baldissera E, Rovere-Querini P, Ruggeri A, Monti G, De Cobelli F, Zangrillo A, Tresoldi M, Castagna A, Dagna L. Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. Eur J Intern Med. 2020 06; 76:43-49. PMID: 32482597.
      Citations: 157     Fields:    Translation:HumansCellsPHPublic Health
    18. Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D, Oltolini C, Castiglioni B, Tassan Din C, Boffini N, Tomelleri A, Farina N, Ruggeri A, Rovere-Querini P, Di Lucca G, Martinenghi S, Scotti R, Tresoldi M, Ciceri F, Landoni G, Zangrillo A, Scarpellini P, Dagna L. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020 Jun; 2(6):e325-e331. PMID: 32501454.
      Citations: 356     
    Della-Torre's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (122)
    Explore
    _
    Co-Authors (86)
    Explore
    _
    Similar People (60)
    Explore
    _